Mark Samuels2019-01-15T21:37:42+00:00

Mark Samuels


Mr. Samuels is a proven entrepreneur and seasoned senior executive with an extensive background in product development, marketing, operations, licensing and capitalization for both public and private companies. As CEO and founder of SpectRx, Inc., he established key strategic development partnerships with Abbott Laboratories, Roche Diagnostics, Respironics, Welch Allyn and others. Mr. Samuels also led research, development and commercialization efforts covering four medical device products, including three now on the market and a non-invasive replacement for cervical cancer screening currently undergoing Phase III pivotal trials.

Mr. Samuels obtained over $22 million of government and strategic partner funding to supplement the $65 million of equity investment raised during his tenure as CEO. This capital helped fund research and development progress that drove the company’s valuation from $1.5 million in 1993 to $180 million by 2000. Mr. Samuels is a named inventor on over nineteen (19) issued U.S patents and a number of U.S. patent applications. In addition to his corporate duties, Mr. Samuels has served as Vice-Chairman of the Georgia BioMedical Partnership, a member of the Georgia Biotechnology Center Advisory Board and was appointed Chairman of the Georgia Senate BioMedical Study Committee by Georgia’s Lt. Governor.